WO2018096375A3 - Méthode de détermination de l'état réceptif de l'endomètre - Google Patents
Méthode de détermination de l'état réceptif de l'endomètre Download PDFInfo
- Publication number
- WO2018096375A3 WO2018096375A3 PCT/HU2017/050049 HU2017050049W WO2018096375A3 WO 2018096375 A3 WO2018096375 A3 WO 2018096375A3 HU 2017050049 W HU2017050049 W HU 2017050049W WO 2018096375 A3 WO2018096375 A3 WO 2018096375A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptive
- endometrium
- determination
- status
- relates
- Prior art date
Links
- 210000004696 endometrium Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne une méthode de détermination de l'état réceptif ou non réceptif de l'endomètre à l'aide d'un échantillon biologique prélevé chez un sujet en âge de procréer, de préférence une patiente humaine. De plus, l'invention concerne un kit de test approprié pour la mise en œuvre de la méthode, ainsi que l'utilisation d'oligonucléotides appropriés pour l'amplification d'ensembles de gènes permettant la détermination de l'état réceptif ou non réceptif de l'endomètre.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17857649.2A EP3545107A2 (fr) | 2016-11-22 | 2017-11-22 | Méthode de détermination de l'état réceptif de l'endomètre |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1600636A HUP1600636A2 (en) | 2016-11-22 | 2016-11-22 | Process for determining receptive status of endometrium |
HU1600637A HUP1600637A2 (en) | 2016-11-22 | 2016-11-22 | Process for determining receptive status of endometrium |
HUP1600636 | 2016-11-22 | ||
HUP1600637 | 2016-11-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018096375A2 WO2018096375A2 (fr) | 2018-05-31 |
WO2018096375A3 true WO2018096375A3 (fr) | 2018-10-04 |
Family
ID=89992311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU2017/050049 WO2018096375A2 (fr) | 2016-11-22 | 2017-11-22 | Méthode de détermination de l'état réceptif de l'endomètre |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3545107A2 (fr) |
WO (1) | WO2018096375A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019246160A2 (fr) * | 2018-06-18 | 2019-12-26 | Igenomix, S.L. | Méthodes, compositions et kits pour l'évaluation de la transformation de l'endomètre |
CN110042156B (zh) * | 2019-04-22 | 2021-12-28 | 苏州亿康医学检验有限公司 | 一种判断子宫内膜容受性的方法及其应用 |
WO2020234026A1 (fr) * | 2019-05-17 | 2020-11-26 | Tervisetehnoloogiate Arenduskeskus As | Détermination de la réceptivité endométriale |
EP3779455A1 (fr) * | 2019-08-14 | 2021-02-17 | Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE | Signatures lipidiques pour déterminer le résultat de l'implantation d'un embryon pendant la fertilisation in vitro |
CN110846400A (zh) * | 2019-10-30 | 2020-02-28 | 吉林大学 | 人外周血循环FST mRNA检测试剂盒及其用途 |
KR102640230B1 (ko) * | 2021-09-24 | 2024-02-22 | 가천대학교 산학협력단 | C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법 |
CN115418340A (zh) * | 2022-06-09 | 2022-12-02 | 中南大学湘雅医院 | 人宫腔灌洗液来源的子宫内膜类器官的培养方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348318A1 (fr) * | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Procédé de diagnostic pour la réceptivité endométriale |
WO2013135836A1 (fr) * | 2012-03-14 | 2013-09-19 | Centre Hospitalier Universitaire Pontchaillou | Itih5 comme marqueur de diagnostic de développement utérin et de défauts fonctionnels |
-
2017
- 2017-11-22 WO PCT/HU2017/050049 patent/WO2018096375A2/fr unknown
- 2017-11-22 EP EP17857649.2A patent/EP3545107A2/fr active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348318A1 (fr) * | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Procédé de diagnostic pour la réceptivité endométriale |
WO2013135836A1 (fr) * | 2012-03-14 | 2013-09-19 | Centre Hospitalier Universitaire Pontchaillou | Itih5 comme marqueur de diagnostic de développement utérin et de défauts fonctionnels |
Non-Patent Citations (9)
Title |
---|
ALISON S. DEVONSHIRE ET AL: "Application of next generation qPCR and sequencing platforms to mRNA biomarker analysis", METHODS, vol. 59, no. 1, 1 January 2013 (2013-01-01), US, pages 89 - 100, XP055228123, ISSN: 1046-2023, DOI: 10.1016/j.ymeth.2012.07.021 * |
ANNA P. PONNAMPALAM ET AL: "Molecular classification of human endometrial cycle stages by transcriptional profiling", MOLECULAR HUMAN REPRODUCTION., vol. 10, no. 12, 1 December 2004 (2004-12-01), GB - BE, pages 879 - 893, XP055471232, ISSN: 1360-9947, DOI: 10.1093/molehr/gah121 * |
DELPHINE HAOUZI ET AL: "Insights into human endometrial receptivity from transcriptomic and proteomic data", REPRODUCTIVE BIOMEDICINE ONLINE, ELSEVIER, AMSTERDAM, NL, vol. 24, no. 1, 15 September 2011 (2011-09-15), pages 23 - 34, XP028122046, ISSN: 1472-6483, [retrieved on 20110929], DOI: 10.1016/J.RBMO.2011.09.009 * |
DIAZ-GIMENO P ET AL: "A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature", FERTILITY AND STERILITY, vol. 95, no. 1, 1 January 2011 (2011-01-01), pages 50 - 60.e15, XP027563196, ISSN: 0015-0282, [retrieved on 20100708] * |
GIUDICE LINDA C: "Application of functional genomics to primate endometrium: insights into biological processes", REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, vol. 4, no. Suppl 1, S4, 9 October 2006 (2006-10-09), XP021024770, ISSN: 1477-7827, DOI: 10.1186/1477-7827-4-S1-S4 * |
MARIA RUIZ-ALONSO ET AL: "The genomics of the human endometrium", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE., vol. 1822, no. 12, 1 December 2012 (2012-12-01), NL, pages 1931 - 1942, XP055471229, ISSN: 0925-4439, DOI: 10.1016/j.bbadis.2012.05.004 * |
TALBI S ET AL: "Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women", ENDOCRINOLOGY, THE ENDOCRINE SOCIETY, US, vol. 147, no. 3, 1 March 2006 (2006-03-01), pages 1097 - 1121, XP002595772, ISSN: 0013-7227, [retrieved on 20060301], DOI: 10.1210/EN.2005-1076 * |
VILELLA F ET AL: "Endometrial fluid transcriptomics as a new non-invasive diagnostic method of uterine receptivity", FERTILITY AND STERILITY, vol. 108, no. 3, 31 October 2017 (2017-10-31), XP085158410, ISSN: 0015-0282, DOI: 10.1016/J.FERTNSTERT.2017.07.156 * |
ZEYNEP H GUMUS: "Wafergen Biosystems SmartChip Human Oncology Panel v2", 1 July 2012 (2012-07-01), pages 1 - 31, XP055495306, Retrieved from the Internet <URL:https://www.ebi.ac.uk/arrayexpress/files/A-GEOD-14610/A-GEOD-14610.adf.txt> [retrieved on 20180725] * |
Also Published As
Publication number | Publication date |
---|---|
WO2018096375A2 (fr) | 2018-05-31 |
EP3545107A2 (fr) | 2019-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018096375A3 (fr) | Méthode de détermination de l'état réceptif de l'endomètre | |
WO2018007872A9 (fr) | Biomarqueurs d'une affection abdominale inflammatoire | |
EP2569453A4 (fr) | Méthodes d'isolement de l'acide nucléique | |
WO2015195949A3 (fr) | Méthodes, compositions et dispositifs pour l'analyse rapide de marqueurs biologiques | |
WO2016015058A3 (fr) | Procédés de détermination de types de tissus et/ou de cellules permettant d'obtenir de l'adn sans cellules, et procédés d'identification d'une maladie ou d'un trouble les employant | |
EP3816303A3 (fr) | Kit ou dispositif de détection du cancer du sein et procédé de détection du cancer du sein | |
PL413090A1 (pl) | Startery, sposób mikrobiologicznej analizy materiału biologicznego, zastosowanie metody sekwencjonowania NGS w diagnostyce mikrobiologicznej i zestaw diagnostyczny | |
WO2012054639A3 (fr) | Systèmes de rmn et procédés de détection rapide d'analytes | |
EP3101407A4 (fr) | Protecteur pour observation par microscopie électronique d'échantillon biologique hydraté, kit pour observation par microscopie électronique, procédé d'observation, de diagnostic, d'évaluation, ou de quantification par microscopie électronique, et support d'échantillon | |
WO2016109813A3 (fr) | Modèles de prédiction de la toxicité neurale basés sur des cellules souches pluripotentes humaines | |
WO2006131537A3 (fr) | Procede permettant de diagnostiquer une tolerance a une greffe immune | |
PE20180402A1 (es) | Procesamiento de mena biologica para el aislamiento de metales pesados | |
AU2016250096A8 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
MX2018001697A (es) | Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores. | |
AU2013252445A8 (en) | Assays, methods and apparatus for assessing RNA disruption | |
MX2019002918A (es) | Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto. | |
BR112019005172A2 (pt) | método e kit para analisar uma amostra | |
WO2016168359A8 (fr) | Procédé et système pour des diagnostics et des traitements thérapeutiques, dérivés du microbiome, de pathologies associées à la santé mentale | |
MX2017009752A (es) | Adn huesped como biomarcador de la enfermedad de crohn. | |
MX2018001373A (es) | Uso de los marcadores moleculares il-3, il-33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincitial y metapneumovirus humano. | |
MY202466A (en) | Methods for treatment of polycystic kidney disease | |
WO2015115923A3 (fr) | Profil de micro-arn dans le sang en tant que test pour la détection du cancer du poumon | |
NZ751193A (en) | Protein biomarkers for diseases associated with the contact activation system | |
WO2015060703A3 (fr) | Kit de diagnostic de la leucemie myeloide chronique en reaction multiplex et ses applications dans le suivi du tratement et de la maladie residuelle | |
WO2018119437A3 (fr) | Méthodes et trousses de diagnostic par électrophorèse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17857649 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2017857649 Country of ref document: EP Effective date: 20190624 |